Serina Therapeutics (SER) Other Accumulated Expenses (2017 - 2026)
Serina Therapeutics (SER) posted Other Accumulated Expenses of $337000.0 for Q4 2025, down 3.71% sequentially from $350000.0 in Q3 2025, and up 74.61% YoY from $193000.0 in Q4 2024.
Serina Therapeutics (SER) Other Accumulated Expenses (2017 - 2026) Analysis & Trends
Serina Therapeutics has reported Other Accumulated Expenses for 6 years, with the latest figure at $337000.0 in Q4 2025.
- Quarterly Other Accumulated Expenses rose 74.61% year-over-year to $337000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $337000.0 (up 74.61% YoY) and the FY2025 annual result came in at $337000.0, up 74.61% from the prior year.
- Other Accumulated Expenses declined to $337000.0 in Q4 2025 per SER's latest filing, from $350000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $545000.0 in Q2 2025 and troughed at $3000.0 in Q1 2024.
- A 4-year average of $215083.3 and a median of $195500.0 in 2024 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses slumped 97.92% in 2024, then surged 10800.0% in 2025.
- Over 4 years, Other Accumulated Expenses stood at $141000.0 in 2022, then soared by 77.3% to $250000.0 in 2023, then retreated by 22.8% to $193000.0 in 2024, then surged by 74.61% to $337000.0 in 2025.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $337000.0, $350000.0, and $545000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 545,000.00 |
| Dec 31, 2025 | 337,000.00 |
| Sep 30, 2025 | 350,000.00 |
| Jun 30, 2025 | 545,000.00 |
| Mar 31, 2025 | 185,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 198,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 250,000.00 |
| Jun 30, 2023 | 230,000.00 |
| Mar 31, 2023 | 144,000.00 |
| Dec 31, 2022 | 141,000.00 |
| Dec 31, 2018 | 625,000.00 |
| Dec 31, 2017 | 154,000.00 |